Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T CellsAaron P. Rapoport, Carl H. June, Nicole A. Aqui et al.|Clinical Cancer Research|2014Cited by 123
Prevalence and significance of vitamin D deficiency in multiple myeloma patientsAshraf Badros, Elizabeth A. Streeten, Olga Goloubeva et al.|British Journal of Haematology|2008Cited by 71
Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: A single center studyVishal Bhatnagar, Ashraf Badros, Yin Wu et al.|Cancer|2014Cited by 55
Supplementary Figure Legends from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T CellsAaron P. Rapoport, Carl H. June, Nicole A. Aqui et al.|Unknown|2023Cited by 0
Supplementary Table 1 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T CellsAaron P. Rapoport, Carl H. June, Nicole A. Aqui et al.|Unknown|2023Cited by 0